Study on Hepatitis B vaccine dosage on children with chronic kidney disease
Phase 2
- Conditions
- Health Condition 1: null- children with chronic kidney disease
- Registration Number
- CTRI/2018/06/014435
- Lead Sponsor
- Chacha Nehru Bal Chikitsalaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All children with diagnosis of CKD stage 2-5 between 1-14 years of age with anti-HBs titer <10 mIU/mL.
Exclusion Criteria
1.Documented history of previous HBV infection or laboratory markers of present or past HBV infection
2.Children with known adverse immune reaction to vaccine.
3.Children on immunosuppressive agents.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method